Search Results

Business

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

MiMedx Group, Inc. announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company’s Senior Vice President, Sales since August 2020.

June 26, 2024

·

1 min read

Business

MIMEDX Announces First Quarter 2024 Operating and Financial Results

MiMedx Group, Inc., announced operating and financial results for the first quarter 2024.

April 30, 2024

·

16 min read

Business

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, April 30, 2024.

April 16, 2024

·

1 min read

MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has issued a determination letter in connection with the RFD process related to AXIOFILL, a human-derived particulate wound dressing.

March 27, 2024

·

5 min read

Press Releases

MIMEDX to Participate in Upcoming Investor Conferences

August 27, 2024

·

1 min read

Business

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the fourth quarter and full year 2023.

February 28, 2024

·

20 min read

Business

MIMEDX Announces Appointment of Two New Independent Directors

MiMedx Group, Inc. announced the appointments of Tiffany Olson and Dorothy Puhy to its Board of Directors, effective as of March 1, 2024.

March 4, 2024

·

2 min read

Press Releases

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

October 15, 2024

·

1 min read

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the TD Cowen 44th Annual Health Care Conference.

February 20, 2024

·

1 min read

BioMidwest

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

MiMedx Group, Inc. announced that it has entered into an agreement with TELA Bio, Inc. to obtain exclusive rights to its manufacturing and supply agreement with Regenity Biosciences that will enable the Company to add xenograft products to its portfolio of Advanced Wound Care and Surgical solutions.

March 20, 2024

·

4 min read